Neos Therapeutics Inc. (NEOS)

1.32
NASDAQ : Health Technology
Prev Close 1.41
Day Low/High 1.30 / 1.43
52 Wk Low/High 1.13 / 6.30
Avg Volume 431.90K
Exchange NASDAQ
Shares Outstanding 49.72M
Market Cap 70.11M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Small Cap Biotech Bargains

Small Cap Biotech Bargains

Here are 2 small caps I continue to see as bargains in this space.

3 Potential Biotech Buyout Targets in the Second Quarter

3 Potential Biotech Buyout Targets in the Second Quarter

Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.

Possible Biotech Takeout Plays

Possible Biotech Takeout Plays

A look at possible second-quarter M&A activity in the biotech sector.

Some Quick Observations

Markets have improved somewhat in the past 90 minutes. The Dow and S&P 500 are now in the black with other major indices nearing even. Some quick observations about some stocks with less than two hours left to end the week. AbbVie clawing back a tad...

Final Hour Starts in the Green

3pm blog update Heading into the homestretch of the trading week. All the major indices remain firmly in the green. Small biotech is having a very strong day, up about two percent this Friday. Some small cap movers today. Synergy Pharmaceuticals nic...

Drug Approvals Don't Always Translate Into Stock Gains: 3 Biotech Examples

Drug Approvals Don't Always Translate Into Stock Gains: 3 Biotech Examples

Winning FDA approval isn't always a win.

Winning FDA Approval Isn't Always a Win

Winning FDA Approval Isn't Always a Win

The experiences of three biotechs show how drug approvals don't always translate into stock gains.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

3 Small Biotechs on the FDA Summer Calendar

3 Small Biotechs on the FDA Summer Calendar

Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.

Halfway Point Points to Biotech, Housing

Halfway Point Points to Biotech, Housing

The two sectors hold more promise than most in the back half of 2017.

3 Post-Earnings Biotech Buys

3 Post-Earnings Biotech Buys

These names are now undervalued, despite solid results and good fundamentals.

3 Post-Earnings Biotech Buys

3 Post-Earnings Biotech Buys

These names are now undervalued, despite solid results and good fundamentals.

Vegas Baby: Rolling '777s' in Biotech

Vegas Baby: Rolling '777s' in Biotech

Three small-cap biotechs with attractive risk/reward profiles.

Two Small Growth Stories

Two Small Growth Stories

An update on two small-caps that reported earnings.